Background and purpose: To improve precision of particle therapy, in vivo range verification is highly desirable. Methods based on prompt gamma rays emitted during treatment seem promising but have not yet been applied clinically. Here we report on the worldwide first clinical application of prompt gamma imaging (PGI) based range verification. Material and methods: A prototype of a knife-edge shaped slit camera was used to measure the prompt gamma ray depth distribution during a proton treatment of a head and neck tumor for seven consecutive fractions. Inter-fractional variations of the prompt gamma profile were evaluated. For three fractions, in-room control CTs were acquired and evaluated for dose relevant changes. Results: The measurement of PGI profiles during proton treatment was successful. Based on the PGI information, inter-fractional global range variations were in the range of +/- 2 mm for all evaluated fractions. This is in agreement with the control CT evaluation showing negligible range variations of about 1.5 mm. Conclusions: For the first time, range verification based on prompt gamma imaging was applied for a clinical proton treatment. With the translation from basic physics experiments into clinical operation, the potential to improve the precision of particle therapy with this technique has increased considerably. (C) 2016 Elsevier Ireland Ltd. All rights reserved.

First clinical application of a prompt gamma based in vivo proton range verification system

BOMBELLI, LUCA;FIORINI, CARLO ETTORE;PERALI, IRENE;
2016

Abstract

Background and purpose: To improve precision of particle therapy, in vivo range verification is highly desirable. Methods based on prompt gamma rays emitted during treatment seem promising but have not yet been applied clinically. Here we report on the worldwide first clinical application of prompt gamma imaging (PGI) based range verification. Material and methods: A prototype of a knife-edge shaped slit camera was used to measure the prompt gamma ray depth distribution during a proton treatment of a head and neck tumor for seven consecutive fractions. Inter-fractional variations of the prompt gamma profile were evaluated. For three fractions, in-room control CTs were acquired and evaluated for dose relevant changes. Results: The measurement of PGI profiles during proton treatment was successful. Based on the PGI information, inter-fractional global range variations were in the range of +/- 2 mm for all evaluated fractions. This is in agreement with the control CT evaluation showing negligible range variations of about 1.5 mm. Conclusions: For the first time, range verification based on prompt gamma imaging was applied for a clinical proton treatment. With the translation from basic physics experiments into clinical operation, the potential to improve the precision of particle therapy with this technique has increased considerably. (C) 2016 Elsevier Ireland Ltd. All rights reserved.
First in man; Prompt gamma imaging; Proton therapy; Range verification; Slit camera; Oncology; Radiology, Nuclear Medicine and Imaging; Hematology, sezele
File in questo prodotto:
File Dimensione Formato  
11311-987548_Bombelli-Fiorini-Perali.pdf

accesso aperto

: Post-Print (DRAFT o Author’s Accepted Manuscript-AAM)
Dimensione 2.12 MB
Formato Adobe PDF
2.12 MB Adobe PDF Visualizza/Apri

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: http://hdl.handle.net/11311/987548
Citazioni
  • ???jsp.display-item.citation.pmc??? 29
  • Scopus 155
  • ???jsp.display-item.citation.isi??? 150
social impact